We are delighted to announce that our portfolio company, 4D Lifetec, was a standout participant at the SACHS ASSOCIATES 5th Annual European HealthTech CEO Forum for Partnering and Investment held on February 27, 2024. 4D Lifetec’s CEO, Dr. Giancarlo Rizzoli, represented the company as a distinguished panelist on the captivating topic, "New Frontiers in Personalized Medicine with AI Powered Diagnostics."

During this dynamic forum, industry leaders engaged in pivotal discussions centered around the revolutionary convergence of AI-powered diagnostics and personalized medicine. Key topics included advancements in treatment detection, leveraging AI for treatment personalization, and navigating the complex landscape of technology and regulatory frameworks.

Stay tuned as anfass Life Technologies and 4D Lifetec continue to be among the leaders in transforming diagnostics through innovation and strategic partnerships.


Sachs EHTF24 178Sachs EHTF24 59Sachs EHTF24 71